Pharma firm eyes reproducing foreign Covid-19 vaccine
A local pharmaceutical company expressed interest in reproducing a coronavirus disease 2019 (Covid-19) vaccine developed by another country.
DOST Undersecretary Rowena Cristina Guevara said the Technical Advisory Group for Vaccine Industry met with nine pharmaceutical firms regarding fill and finish type manufacturing, which involves packaging vaccines after production.
The DOST is considering this method as a starting point for local vaccine reproduction due to lack of facilities for full development and manufacturing.
Guevara also confirmed that clinical trials for other countries' vaccines are welcome if they meet FDA approval requirements.
This story was generated by AI to help you understand the key points. For more detailed coverage, please see the news articles from trusted media outlets below.